IMVT
Price
$25.88
Change
+$0.22 (+0.86%)
Updated
Dec 20, 04:59 PM (EDT)
53 days until earnings call
KYMR
Price
$40.64
Change
+$1.50 (+3.83%)
Updated
Dec 20, 04:59 PM (EDT)
61 days until earnings call
Ad is loading...

IMVT vs KYMR

Header iconIMVT vs KYMR Comparison
Open Charts IMVT vs KYMRBanner chart's image
Immunovant
Price$25.88
Change+$0.22 (+0.86%)
Volume$47.12K
CapitalizationN/A
Kymera Therapeutics
Price$40.64
Change+$1.50 (+3.83%)
Volume$9.94K
CapitalizationN/A
IMVT vs KYMR Comparison Chart
Loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMVT vs. KYMR commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and KYMR is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (IMVT: $25.88 vs. KYMR: $40.64)
Brand notoriety: IMVT and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 363% vs. KYMR: 250%
Market capitalization -- IMVT: $3.8B vs. KYMR: $2.63B
IMVT [@Biotechnology] is valued at $3.8B. KYMR’s [@Biotechnology] market capitalization is $2.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 5 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than KYMR.

Price Growth

IMVT (@Biotechnology) experienced а -1.52% price change this week, while KYMR (@Biotechnology) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

IMVT is expected to report earnings on Feb 12, 2025.

KYMR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($3.8B) has a higher market cap than KYMR($2.63B). KYMR YTD gains are higher at: 59.623 vs. IMVT (-38.571). KYMR has higher annual earnings (EBITDA): -160.96M vs. IMVT (-352.16M). KYMR has more cash in the bank: 550M vs. IMVT (473M). IMVT has less debt than KYMR: IMVT (47K) vs KYMR (88.2M). KYMR has higher revenues than IMVT: KYMR (87.6M) vs IMVT (0).
IMVTKYMRIMVT / KYMR
Capitalization3.8B2.63B144%
EBITDA-352.16M-160.96M219%
Gain YTD-38.57159.623-65%
P/E RatioN/AN/A-
Revenue087.6M-
Total Cash473M550M86%
Total Debt47K88.2M0%
TECHNICAL ANALYSIS
Technical Analysis
IMVTKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 6 days ago
83%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HMVTX17.910.22
+1.24%
Hartford MidCap Value R5
VPMCX161.181.62
+1.02%
Vanguard PRIMECAP Inv
DIECX37.860.01
+0.03%
BNY Mellon International Core Equity C
RREMX13.26N/A
N/A
RBC Emerging Markets Equity R6
EQIRX11.86-0.01
-0.10%
Allspring Emerging Markets Eq Inc R6

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+0.86%
ROIV - IMVT
58%
Loosely correlated
+0.61%
BRNS - IMVT
48%
Loosely correlated
+1.96%
ARGX - IMVT
45%
Loosely correlated
-0.35%
SNDX - IMVT
39%
Loosely correlated
+1.79%
KYMR - IMVT
39%
Loosely correlated
+3.83%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+3.83%
CCCC - KYMR
61%
Loosely correlated
+2.60%
RXRX - KYMR
47%
Loosely correlated
-0.90%
CRSP - KYMR
45%
Loosely correlated
+0.83%
XENE - KYMR
45%
Loosely correlated
-0.54%
TRDA - KYMR
45%
Loosely correlated
+1.85%
More